Mario Otto

1.2k total citations
32 papers, 899 citations indexed

About

Mario Otto is a scholar working on Immunology, Neurology and Oncology. According to data from OpenAlex, Mario Otto has authored 32 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Neurology and 11 papers in Oncology. Recurrent topics in Mario Otto's work include Neuroblastoma Research and Treatments (13 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (7 papers). Mario Otto is often cited by papers focused on Neuroblastoma Research and Treatments (13 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (7 papers). Mario Otto collaborates with scholars based in United States, Germany and China. Mario Otto's co-authors include Raymond Barfield, Rupert Handgretinger, Thasia Leimig, Stephen D. Gillies, Rekha Iyengar, Terrence L. Geiger, James Houston, Wing Leung, Prashant Sharma and Martha Holladay and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Mario Otto

32 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Otto United States 16 390 325 249 234 187 32 899
Donna M. Hess United States 12 742 1.9× 143 0.4× 101 0.4× 71 0.3× 171 0.9× 22 1.3k
Steven I. Park United States 18 153 0.4× 571 1.8× 206 0.8× 59 0.3× 160 0.9× 65 1.1k
Marie Favrot France 21 304 0.8× 408 1.3× 150 0.6× 100 0.4× 947 5.1× 34 1.8k
Joan García‐López Spain 14 263 0.7× 210 0.6× 33 0.1× 510 2.2× 259 1.4× 20 1.1k
F. B. Oldham United States 15 106 0.3× 397 1.2× 44 0.2× 300 1.3× 270 1.4× 31 939
Eva Rettinger Germany 19 518 1.3× 547 1.7× 40 0.2× 321 1.4× 147 0.8× 51 991
Cynthia Nourigat United States 11 153 0.4× 199 0.6× 32 0.1× 314 1.3× 462 2.5× 14 1.0k
Duohui Jing Germany 14 119 0.3× 172 0.5× 41 0.2× 287 1.2× 274 1.5× 22 905
Richard Noppeney Germany 15 343 0.9× 708 2.2× 67 0.3× 291 1.2× 357 1.9× 31 1.3k
Biagio De Angelis Italy 22 774 2.0× 1.2k 3.6× 109 0.4× 141 0.6× 543 2.9× 44 1.7k

Countries citing papers authored by Mario Otto

Since Specialization
Citations

This map shows the geographic impact of Mario Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Otto more than expected).

Fields of papers citing papers by Mario Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Otto. The network helps show where Mario Otto may publish in the future.

Co-authorship network of co-authors of Mario Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Otto. A scholar is included among the top collaborators of Mario Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Otto. Mario Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Prashant & Mario Otto. (2023). Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy. Bioactive Materials. 31. 440–462. 36 indexed citations
2.
3.
Hall, Lance T., Anja G. van der Kolk, H. Ian Robins, et al.. (2019). [124I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors. Molecular Imaging and Biology. 22(2). 434–443. 7 indexed citations
4.
Marsh, Ian R., Joseph J. Grudzinski, Dana C. Baiu, et al.. (2019). Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models. Journal of Nuclear Medicine. 60(10). 1414–1420. 18 indexed citations
5.
Baiu, Dana C., Chunrong Li, Lauryn R. Werner, et al.. (2018). Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Molecular Cancer Therapeutics. 17(11). 2320–2328. 4 indexed citations
6.
Bednarz, Bryan P., Joseph J. Grudzinski, Ian R. Marsh, et al.. (2018). Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Physics. 114(4). 450–459. 10 indexed citations
7.
Otto, Mario, et al.. (2018). TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data. Leukemia & lymphoma. 60(3). 598–609. 8 indexed citations
8.
Baiu, Dana C., Ian R. Marsh, Saswati Bhattacharya, et al.. (2017). Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog. Journal of Nuclear Medicine. 59(2). 244–250. 13 indexed citations
9.
McDowell, Kimberly A., Jacquelyn A. Hank, Kenneth B. DeSantes, et al.. (2015). NK Cell-based Immunotherapies in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 37(2). 79–93. 17 indexed citations
10.
Xu, Yaolin, Dana C. Baiu, Jennifer Sherwood, et al.. (2014). Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles. Journal of Materials Chemistry B. 2(37). 6198–6198. 34 indexed citations
11.
Capitini, Christian M., Mario Otto, Kenneth B. DeSantes, & Paul M. Sondel. (2014). Immunotherapy in Pediatric Malignancies: Current Status and Future Perspectives. Future Oncology. 10(9). 1659–1678. 9 indexed citations
12.
Baiu, Dana C., Christopher S. Brazel, Yuping Bao, & Mario Otto. (2013). Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology. Current Pharmaceutical Design. 19(37). 6606–6621. 14 indexed citations
13.
14.
Jiao, Peifu, Hongyu Zhou, Mario Otto, et al.. (2011). Leading Neuroblastoma Cells To Die by Multiple Premeditated Attacks from a Multifunctionalized Nanoconstruct. Journal of the American Chemical Society. 133(35). 13918–13921. 28 indexed citations
15.
Chaleff, Stanley, Mario Otto, Raymond Barfield, et al.. (2007). A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy. 9(8). 746–754. 77 indexed citations
16.
Otto, Mario, Raymond Barfield, Rekha Iyengar, et al.. (2004). Human ???? T Cells From G-CSF-Mobilized Donors Retain Strong Tumoricidal Activity and Produce Immunomodulatory Cytokines After Clinical-Scale Isolation. Journal of Immunotherapy. 28(1). 73–78. 31 indexed citations
17.
Barfield, Raymond, Mario Otto, James Houston, et al.. (2004). A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy. 6(1). 1–6. 63 indexed citations
18.
Iyengar, Rekha, Rupert Handgretinger, Thasia Leimig, et al.. (2003). Purification of human natural killer cells using a clinical-scale immunomagnetic method. Cytotherapy. 5(6). 479–484. 59 indexed citations
19.
Weibrich, Gernot, et al.. (2002). Wachstumsstimulation von humanen osteoblastenähnlichen Zellen durch Thrombozytenkonzentrate in vitro. Mund- Kiefer- und Gesichtschirurgie. 6(3). 168–174. 56 indexed citations
20.
Hartmann, Andreas, et al.. (1991). Hitherto Unknown Additive Growth Effects of Fluorene and 2-Acetylaminofluorene on Bile Duct Epithelium and Hepatocytes in Rats. Archives of toxicology. Supplement. 14. 71–74. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna M. Hess Breakdown of academic impact, for papers by Steven I. Park Breakdown of academic impact, for papers by Marie Favrot Breakdown of academic impact, for papers by Joan García‐López Breakdown of academic impact, for papers by F. B. Oldham Breakdown of academic impact, for papers by Eva Rettinger Breakdown of academic impact, for papers by Cynthia Nourigat Breakdown of academic impact, for papers by Duohui Jing Breakdown of academic impact, for papers by Richard Noppeney Breakdown of academic impact, for papers by Biagio De Angelis
Rankless by CCL
2026